Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Celastrol
Nanjing Legend Biotech Co.
Safety Issues
1 trial -
Chemotherapy drug
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma, Adult
1 trial -
Chi-GVM
The First People's Hospital of Lianyungang
Relapsed/Refractory Peripheral T-cell Lymphoma
1 trial -
Chronotropic Incompetence Diagnostic Algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Cigarette
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
1 trial -
Ciprofloxacin
United Therapeutics Europe Ltd
Acute Lymphoblastic Leukaemia - Category
1 trial -
Clarithromycin
Chinese University of Hong Kong
Bronchiectasis Adult
1 trial -
Clarithromycin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Rhinosinusitis
1 trial -
Coenzyme Q10
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Colchicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transcatheter Aortic Valve Replacement
1 trial -
Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Primary Prevention Strategy
1 trial -
Cy-TB test
International Peace Maternity and Child Health Hospital
Latent Tuberculosis
1 trial -
D-Galactose
United Therapeutics Europe Ltd
Focal Segmental Glomerulosclerosis
1 trial -
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
DC-TC+GM-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Hepatocellular Carcinoma
1 trial -
DGB-01 Supplementation
Blackmores Limited
Fatigue
1 trial -
DHA-piperaquine
United Therapeutics Europe Ltd
Malaria
1 trial -
DM199
DiaMedica Therapeutics
Pre-Eclampsia
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Dasatinib
The First People's Hospital of Lianyungang
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 trial -
Deucravacitinib
The First People's Hospital of Lianyungang
Palmoplantar Pustulosis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources